☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
NMPA’s
Zai Lab and Novocure's Optune Receive NMPA's Innovative Medical Device Designation for its Tumor Treating Field Delivery System
August 12, 2019
BioMarin's Vimizim (elosulfase alfa) Receives NMPA's (CFDA) Approval for Treatment of Morquio A Syndrome
June 5, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.
